Laudanosine
![]() |
|
Names | |
---|---|
IUPAC name
(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy- 2-methyl-3,4-dihydro-1H-isoquinoline
|
|
Other names
N-Methyl-1,2,3,4-tetrahydropapaverine
|
|
Identifiers | |
2688-77-9 ![]() |
|
ChemSpider | 66114 ![]() |
EC Number | 220-253-2 |
Jmol 3D model | Interactive image |
PubChem | 73397 |
|
|
|
|
Properties | |
C21H27NO4 | |
Molar mass | 357.45 g·mol−1 |
Melting point | 89 °C (192 °F; 362 K) |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Laudanosine or N-methyltetrahydropapaverine is a recognized metabolite[1] of atracurium and cisatracurium. Laudanosine decreases the seizure threshold, and thus it can induce seizures if present at sufficient threshold concentrations; however such concentrations are unlikely to be produced consequent to chemodegradable metabolism of clinically administered doses of cisatracurium or atracurium.
Laudanosine also occurs naturally in minute amounts (0.1%) in opium, from which it was first isolated in 1871.[2] Partial dehydrogenation of laudanosine will lead to papaverine, the alkaloid found in the opium poppy plant (Papaver somniferum).
Laudanosine is a benzyltetrahydroisoquinoline alkaloid. It has been shown to interact with GABA receptors, glycine receptors, opioid receptors, and nicotinic acetylcholine receptors,[1][3][4] but not benzodiazepine or muscarinic receptors which are also involved in epilepsy and other types of seizures.[5]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
Receptor (ligands) |
|
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (blockers) |
|
||||||||||||||||||||||||||||||
Enzyme (inhibitors) |
|
||||||||||||||||||||||||||||||
Others |
|
||||||||||||||||||||||||||||||
Receptor (ligands) |
|
||||
---|---|---|---|---|---|
Transporter (blockers) |
|
||||
Others |
|
||||
Receptor (ligands) |
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme (inhibitors) |
|
||||||||||
Others |
|
||||||||||
See also: Template:Peptide receptor modulators
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found. Retrieved September 18, 2008 through Google Book Search.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Articles without EBI source
- Articles without KEGG source
- Articles without UNII source
- Articles with changed InChI identifier
- Pages using collapsible list with both background and text-align in titlestyle
- Tetrahydroisoquinolines
- Natural opium alkaloids
- Phenol ethers
- Convulsants
- GABAA receptor negative allosteric modulators
- Glycine receptor antagonists
- Nicotinic antagonists
- Nervous system drug stubs